Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Roles of Bcl-3 in the pathogenesis of murine type 1 diabetes.

Ruan Q, Zheng SJ, Palmer S, Carmody RJ, Chen YH.

Diabetes. 2010 Oct;59(10):2549-57. doi: 10.2337/db10-0480. Epub 2010 Jul 9.

2.

BCL-6 regulates chemokine gene transcription in macrophages.

Toney LM, Cattoretti G, Graf JA, Merghoub T, Pandolfi PP, Dalla-Favera R, Ye BH, Dent AL.

Nat Immunol. 2000 Sep;1(3):214-20.

PMID:
10973278
3.

Inhibition of Th2 differentiation and GATA-3 expression by BCL-6.

Kusam S, Toney LM, Sato H, Dent AL.

J Immunol. 2003 Mar 1;170(5):2435-41.

4.

Interleukin-21 is required for the development of type 1 diabetes in NOD mice.

Sutherland AP, Van Belle T, Wurster AL, Suto A, Michaud M, Zhang D, Grusby MJ, von Herrath M.

Diabetes. 2009 May;58(5):1144-55. doi: 10.2337/db08-0882. Epub 2009 Feb 10.

5.

A Reg family protein is overexpressed in islets from a patient with new-onset type 1 diabetes and acts as T-cell autoantigen in NOD mice.

Gurr W, Yavari R, Wen L, Shaw M, Mora C, Christa L, Sherwin RS.

Diabetes. 2002 Feb;51(2):339-46.

7.

Characterization of the role of major histocompatibility complex in type 1 diabetes recurrence after islet transplantation.

Young HY, Zucker P, Flavell RA, Jevnikar AM, Singh B.

Transplantation. 2004 Aug 27;78(4):509-15.

PMID:
15446308
8.
9.
10.

Prevention of type 1 diabetes in NOD mice by genetic engineering of hematopoietic stem cells.

Bagley J, Tian C, Iacomini J.

Methods Mol Biol. 2008;433:277-85. doi: 10.1007/978-1-59745-237-3_17.

PMID:
18679630
11.

Genetic and therapeutic control of diabetogenic CD8+ T cells.

Santamaria P.

Novartis Found Symp. 2008;292:130-6; discussion 136-45, 202-3.

PMID:
19209463
12.

Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice.

Balasa B, Lee J, Sarvetnick N.

Cell Immunol. 1999 May 1;193(2):170-8.

PMID:
10222059
13.

Regulation of the IL-21 gene by the NF-κB transcription factor c-Rel.

Chen G, Hardy K, Bunting K, Daley S, Ma L, Shannon MF.

J Immunol. 2010 Aug 15;185(4):2350-9. doi: 10.4049/jimmunol.1000317. Epub 2010 Jul 16.

14.

Islet expression of M3 uncovers a key role for chemokines in the development and recruitment of diabetogenic cells in NOD mice.

Martin AP, Grisotto MG, Canasto-Chibuque C, Kunkel SL, Bromberg JS, Furtado GC, Lira SA.

Diabetes. 2008 Feb;57(2):387-94. Epub 2007 Nov 14.

15.

BCL-6 negatively regulates macrophage proliferation by suppressing autocrine IL-6 production.

Yu RY, Wang X, Pixley FJ, Yu JJ, Dent AL, Broxmeyer HE, Stanley ER, Ye BH.

Blood. 2005 Feb 15;105(4):1777-84. Epub 2004 Oct 26.

16.

Abnormal organogenesis of Peyer's patches in mice deficient for NF-kappaB1, NF-kappaB2, and Bcl-3.

Paxian S, Merkle H, Riemann M, Wilda M, Adler G, Hameister H, Liptay S, Pfeffer K, Schmid RM.

Gastroenterology. 2002 Jun;122(7):1853-68.

PMID:
12055593
17.

Bcl6 is a transcriptional repressor for the IL-18 gene.

Takeda N, Arima M, Tsuruoka N, Okada S, Hatano M, Sakamoto A, Kohno Y, Tokuhisa T.

J Immunol. 2003 Jul 1;171(1):426-31.

18.

Insulin transactivator MafA regulates intrathymic expression of insulin and affects susceptibility to type 1 diabetes.

Noso S, Kataoka K, Kawabata Y, Babaya N, Hiromine Y, Yamaji K, Fujisawa T, Aramata S, Kudo T, Takahashi S, Ikegami H.

Diabetes. 2010 Oct;59(10):2579-87. doi: 10.2337/db10-0476. Epub 2010 Aug 3.

19.

Mutation analysis of left-right axis determining genes in NOD and ICR, strains susceptible to maternal diabetes.

Maeyama K, Kosaki R, Yoshihashi H, Casey B, Kosaki K.

Teratology. 2001 Mar;63(3):119-26.

PMID:
11283968
20.

Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.

Trembleau S, Penna G, Gregori S, Chapman HD, Serreze DV, Magram J, Adorini L.

J Immunol. 1999 Sep 1;163(5):2960-8.

Supplemental Content

Support Center